Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...

Artificial intelligence (AI) is revolutionising how scientists study cancer and Type 1 diabetes and discover ways to fight them.

ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.

A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is ...

In multidisciplinary settings, AI summarizes evidence for each specialist and speeds up consensus. Trials show it can help ...

Nil Adell-Mill is pioneering a new era of chemistry by teaching machines to innovate through biology-inspired models, ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Quantum technology is rapidly emerging as one of the most revolutionary scientific advances of the 21st century. Unlike classical technologies, which Quantum technology is rapidly emerging as one of ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A Western-led interdisciplinary research team is using artificial intelligence (AI) to target a potentially harmful enzyme found in the human body ...